Imaging Stocks List

Imaging Stocks Recent News

Date Stock Title
Nov 21 JAZZ Zymeworks, Jazz Pharmaceuticals Receive FDA's Accelerated Approval for Ziihera to Treat Biliary Tract Cancer
Nov 21 JAZZ Jazz and Zymeworks announce FDA approval of cancer therapy Ziihera
Nov 21 BR Broadridge Significantly Enhances Structured Product Trading Capabilities
Nov 21 JAZZ Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)
Nov 20 VREX Varex Imaging Corp (VREX) Q4 2024 Earnings Call Highlights: Strategic Investments and Global ...
Nov 20 VREX Varex Imaging Corporation (VREX) Q4 2024 Earnings Call Transcript
Nov 19 VREX Varex Imaging Non-GAAP EPS of $0.19 beats by $0.10, revenue of $206M beats by $6.6M
Nov 19 VREX Varex Announces Financial Results for Fourth Quarter and Fiscal Year 2024
Nov 19 JAZZ Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference
Nov 19 JAZZ Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock?
Nov 19 JAZZ Silver Ring Value Partners: Jazz Pharmaceuticals (JAZZ) Is a “High Uncertainty With Low Risk” Investment
Nov 19 VREX Earnings Scheduled For November 19, 2024
Nov 18 VREX Varex Imaging Q4 2024 Earnings Preview
Nov 18 JAZZ Jazz Pharmaceuticals: High Uncertainty, Low Risk
Nov 18 JAZZ Is Jazz Pharmaceuticals plc (JAZZ) the Best Immunotherapy Stock to Buy Now?
Nov 15 POCI Precision Optics Corporation, Inc. (POCI) Q1 2025 Earnings Call Transcript
Nov 14 POCI Precision Optics GAAP EPS of -$0.21, revenue of $4.19M
Nov 14 POCI Precision Optics Receives Initial Production Order for Single-Use Ophthalmic Program
Nov 14 POCI Precision Optics Reports First Quarter Fiscal Year 2025 Financial Results
Imaging

Imaging is the representation or reproduction of an object's form; especially a visual representation (i.e., the formation of an image).

Browse All Tags